Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa
2008; Elsevier BV; Volume: 26; Issue: 22 Linguagem: Inglês
10.1016/j.vaccine.2008.02.071
ISSN1873-2518
AutoresWalter Jaoko, Frederick N. Nakwagala, Omu Anzala, Gloria Omosa Manyonyi, Josephine Birungi, Annet Nanvubya, Bashir Farah, Kirana Bhatt, Hilda Ogutu, Sabina Wakasiaka, Lucy Matu, Wambui Waruingi, Jane Odada, Micah Oyaro, Jackton Indangasi, Jeckonia Ndinya-Achola, Carol Konde, Emmanuel Mugisha, Patricia Fast, Claudia Schmidt, Jill Gilmour, Tony Tarragona, Carol Smith, Burc Barin, Len Dally, Bruce Johnson, Andrew Muluubya, Leslie Nielsen, Peter Hayes, Mark Boaz, Peter J. Hughes, Tomáš Hanke, Andrew J. McMichael, Job J. Bwayo, Pontiano Kaleebu,
Tópico(s)Herpesvirus Infections and Treatments
Referência(s)